Login to Your Account



British Biotech, RiboTargets Plan Merger Despite Reduced Valuation

By Nuala Moran


Wednesday, March 26, 2003
LONDON - After two years of searching, British Biotech plc finally landed a merger partner, privately held RiboTargets Holdings plc, a structure-based drug discovery specialist that brings £19 million (US$30 million) to add to British Biotech's £32 million cash pile. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription